Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer
This prognostic study examines the utility of tumor-stroma proportion as a predictive biomarker for chemoresistance among patients with ovarian cancer.
This prognostic study examines the utility of tumor-stroma proportion as a predictive biomarker for chemoresistance among patients with ovarian cancer.
Persons who witness an out-of-hospital cardiac arrest (OHCA)—that is, bystanders—have the capacity to institute essential, primary steps of resuscitation, including cardiopulmonary resuscitation (CPR) and defibrillation…
This randomized clinical trial analyzes data for patients with acute noncardioembolic stroke who were given intravenous tirofiban within 24 hours of stroke onset to gauge…
Watch this previously recorded webinar to hear about the latest treatments and research on inflammatory breast cancer from Dr. Wendy Woodward of MD Anderson.
Background: Loneliness, a subjective feeling of being isolated, is a prevalent concern for elderly people and more so among cancer survivors because a cancer diagnosis…
Hide glossary Study record managers: ref er to the Data Element Definitions if submitting registration or results information.
Background: Little is known as to whether the effects of physician sex on patients’ clinical outcomes vary by patient sex. Objective: To examine whether the…
Myeloma Paper of the Day, April 26th, suggested by Robert Orlowski / AL Amyloidosis, amyloidosis, blood advances, cancer, CHIP, clonal hematopoiesis, Clonal
Richter Transformation (RT) refers to the development of an aggressive lymphoma in the setting of chronic lymphocytic leukemia (CLL). While many variants of RT are…
Newsletters Governor’s Newsletter February 2024 Governor’s Newsletter December 2023 Governor’s Newsletter September 2023 Governor’s Newsletter June 2023
Magnus Nilsson, MD, PhD, FACS, Karolinska University Hospital, Stockholm, Sweden, discusses findings from the Phase III SANO-trial (NTR6803 8-11-2017) a noni…